The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

As bird flu continues to threaten animals and public health, the U.S. government has stepped up its response. Experts says it ...

The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

TikToker Magda, who goes by @magdacious on TikTok, posted a viral video announcing a new series she plans on creating: ...

The new bird flu vaccine deal marks the second deal the company bagged after the $176-million H5N1 avian influenza virus awarded earlier. Moderna was previously awarded funds to develop a COVID-19 ...

Moderna’s vaccine is designed to target H5 and H7 avian influenza viruses. HealthDay News — The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company ...

In that vein, let's learn about the three most important things you should know if you're going to consider investing in ...

Moderna’s vaccine is designed to target H5 and H7 avian influenza viruses. The company plans to move into phase 3 clinical trials to test the vaccine in a larger group of people after receiving ...